Competitive Generic Therapies: Off-Patent Drugs With 1 Source
✉ Email this page to a colleague
This table lists drugs which, despite having no patents or regulatory protections, have a limited number of active sources.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Strength |
|---|---|---|---|---|---|---|---|---|---|---|
| Mission Pharma | LITHOSTAT | acetohydroxamic acid | TABLET;ORAL | 018749-001 | May 31, 1983 | RX | Yes | Yes | 250MG | |
| Bausch And Lomb | MIOCHOL-E | acetylcholine chloride | FOR SOLUTION;OPHTHALMIC | 020213-001 | Sep 22, 1993 | RX | Yes | Yes | 20MG/VIAL | |
| Bausch | XERESE | acyclovir; hydrocortisone | CREAM;TOPICAL | 022436-001 | Jul 31, 2009 | RX | Yes | Yes | 5%;1% | |
| 3m | AVAGARD | alcohol; chlorhexidine gluconate | SOLUTION;TOPICAL | 021074-001 | Jun 7, 2001 | OTC | Yes | Yes | 61%;1% | |
| Rising | ALFENTA | alfentanil hydrochloride | INJECTABLE;INJECTION | 019353-001 | Dec 29, 1986 | RX | Yes | Yes | EQ 0.5MG BASE/ML | |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Strength |
